Notify me when Cormorant Asset Management, LP files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 32 | $1,763,992,777 | +$158,850,176 | -$423,997,347 | -$265,147,171 | PRAX, BBOT, ABVX, EYPT, RAPP | 13F-HR | 17 Feb 2026, 15:00 |
| Q3 2025 | 36 | $1,449,259,159 | +$245,102,267 | -$329,747,223 | -$84,644,956 | BBOT, ABVX, EYPT, RAPP, BBIO | 13F-HR | 14 Nov 2025, 13:03 |
| Q2 2025 | 42 | $1,342,486,545 | +$67,487,014 | -$136,202,714 | -$68,715,700 | MLTX, EYPT, BBIO, PRAX, MRUS | 13F-HR | 14 Aug 2025, 15:36 |
| Q1 2025 | 42 | $1,320,779,265 | +$97,067,604 | -$172,937,613 | -$75,870,009 | MLTX, EWTX, BBIO, ACLX, PRAX | 13F-HR | 15 May 2025, 15:22 |
| Q4 2024 | 48 | $1,820,860,799 | +$260,915,006 | -$240,111,402 | +$20,803,604 | MLTX, PRAX, JANX, ACLX, EWTX | 13F-HR | 14 Feb 2025, 15:01 |
| Q3 2024 | 45 | $1,885,759,705 | +$142,082,984 | -$157,326,566 | -$15,243,582 | MLTX, PCVX, ACLX, LBPH, EWTX | 13F-HR | 14 Nov 2024, 15:11 |
| Q2 2024 | 47 | $1,719,391,869 | +$351,015,509 | -$590,590,808 | -$239,575,299 | MLTX, CRBP, ACLX, PCVX, LBPH | 13F-HR | 14 Aug 2024, 15:05 |
| Q1 2024 | 56 | $2,269,736,201 | +$568,656,118 | -$503,532,849 | +$65,123,269 | MLTX, EYPT, ACLX, ALPN, BBIO | 13F-HR | 15 May 2024, 15:22 |
| Q4 2023 | 47 | $2,088,803,226 | +$533,536,505 | -$613,037,468 | -$79,500,963 | MLTX, AMAM, EYPT, BBIO, ACLX | 13F-HR | 14 Feb 2024, 15:11 |
| Q3 2023 | 49 | $1,714,347,327 | +$289,854,336 | -$253,414,793 | +$36,439,543 | MLTX, BBIO, AMAM, ACLX, APLS | 13F-HR | 14 Nov 2023, 15:25 |
| Q2 2023 | 61 | $1,755,848,549 | +$300,200,368 | -$426,182,392 | -$125,982,024 | MLTX, AMAM, APLS, BMEA, BBIO | 13F-HR | 14 Aug 2023, 15:19 |
| Q1 2023 | 72 | $1,518,444,000 | +$318,532,243 | -$333,894,509 | -$15,362,266 | RXDX, MLTX, BMEA, APLS, AMAM | 13F-HR | 15 May 2023, 15:34 |
| Q4 2022 | 72 | $1,487,868,000 | +$180,863,334 | -$213,052,472 | -$32,189,138 | RXDX, APLS, ACLX, MLTX, RNA | 13F-HR | 14 Feb 2023, 15:17 |
| Q3 2022 | 72 | $1,421,730,000 | +$267,756,231 | -$365,324,703 | -$97,568,472 | RXDX, APLS, DSGN, ERAS, ACLX | 13F-HR | 14 Nov 2022, 15:23 |
| Q2 2022 | 79 | $1,289,141,000 | +$253,118,894 | -$183,372,452 | +$69,746,442 | TPTX, DSGN, ERAS, RXDX, APLS | 13F-HR | 15 Aug 2022, 15:08 |
| Q1 2022 | 77 | $1,302,462,000 | +$229,910,615 | -$125,983,429 | +$103,927,186 | TPTX, ERAS, DSGN, RXDX, GRNA | 13F-HR | 16 May 2022, 15:07 |
| Q4 2021 | 78 | $1,681,198,000 | +$151,567,511 | -$343,931,135 | -$192,363,624 | ERAS, TPTX, DSGN, RXDX, FMTX | 13F-HR | 14 Feb 2022, 15:19 |
| Q3 2021 | 88 | $2,461,043,000 | +$464,695,135 | -$347,712,525 | +$116,982,610 | ERAS, TPTX, AVIR, FMTX, RVMD | 13F-HR | 15 Nov 2021, 15:14 |
| Q2 2021 | 100 | $2,564,684,000 | +$486,933,806 | -$886,508,584 | -$399,574,778 | TPTX, AVIR, FMTX, BBIO, DSGN | 13F-HR | 16 Aug 2021, 15:13 |
| Q1 2021 | 115 | $3,472,944,000 | +$727,828,164 | -$418,702,335 | +$309,125,829 | AVIR, TPTX, DSGN, BBIO, FMTX | 13F-HR | 17 May 2021, 15:46 |
| Q4 2020 | 99 | $3,440,103,000 | +$1,012,081,078 | -$450,000,611 | +$562,080,467 | TPTX, AVIR, BBIO, FMTX, OLMA | 13F-HR | 16 Feb 2021, 15:21 |
| Q3 2020 | 87 | $2,273,248,000 | +$328,939,815 | -$448,990,409 | -$120,050,594 | TPTX, FMTX, RVMD, BBIO, CCXI | 13F-HR | 16 Nov 2020, 16:13 |
| Q2 2020 | 77 | $2,279,775,000 | +$364,271,352 | -$412,922,917 | -$48,651,565 | TPTX, FMTX, CCXI, PRNB, BBIO | 13F-HR | 14 Aug 2020, 15:17 |
| Q1 2020 | 68 | $1,755,344,000 | +$315,671,285 | -$284,878,604 | +$30,792,681 | TPTX, PRNB, BBIO, CCXI, XLRN | 13F-HR | 15 May 2020, 15:07 |
| Q4 2019 | 61 | $2,271,017,000 | +$452,878,784 | -$307,153,240 | +$145,725,544 | TPTX, RETA, MRTX, CCXI, PRNB | 13F-HR | 14 Feb 2020, 15:36 |
| Q3 2019 | 68 | $1,383,388,000 | +$167,517,382 | -$125,109,912 | +$42,407,470 | TPTX, MRTX, APLS, RETA, BBIO | 13F-HR | 14 Nov 2019, 15:10 |
| Q2 2019 | 67 | $1,580,760,000 | +$458,730,808 | -$243,554,788 | +$215,176,020 | TPTX, MRTX, RETA, APLS, BBIO | 13F-HR | 14 Aug 2019, 15:17 |
| Q1 2019 | 63 | $1,395,793,000 | +$414,085,358 | -$402,390,497 | +$11,694,861 | IFRX, MRTX, ASND, APLS, ANAB | 13F-HR | 15 May 2019, 15:31 |
| Q4 2018 | 65 | $1,101,664,000 | +$159,161,303 | -$162,730,622 | -$3,569,319 | MRTX, ANAB, TSRO, APLS, IFRX | 13F-HR | 14 Feb 2019, 15:35 |
| Q3 2018 | 60 | $1,394,397,000 | +$170,326,435 | -$189,828,221 | -$19,501,786 | ANAB, MRTX, NKTR, AVRO, APLS | 13F-HR | 14 Nov 2018, 15:15 |
| Q2 2018 | 56 | $1,244,508,000 | +$275,254,849 | -$107,558,768 | +$167,696,081 | APLS, MRTX, ANAB, NKTR, IFRX | 13F-HR | 14 Aug 2018, 15:11 |
| Q1 2018 | 49 | $1,154,525,000 | +$250,295,718 | -$120,933,016 | +$129,362,702 | NKTR, ANAB, APLS, MRTX, IFRX | 13F-HR | 15 May 2018, 15:54 |
| Q4 2017 | 49 | $862,911,000 | +$421,126,419 | -$202,951,645 | +$218,174,774 | ANAB, NKTR, APLS, BPMC, MYOK | 13F-HR | 14 Feb 2018, 15:39 |
| Q3 2017 | 51 | $566,356,000 | +$110,584,371 | -$217,179,650 | -$106,595,279 | MYOK, RXDX, OMER, ANAB, TBPH | 13F-HR | 14 Nov 2017, 15:17 |
| Q2 2017 | 71 | $602,354,000 | +$112,295,094 | -$156,414,902 | -$44,119,808 | PTLA, TBPH, BLUE, QTNT, OMER | 13F-HR | 14 Aug 2017, 15:15 |
| Q1 2017 | 75 | $688,685,000 | +$62,438,743 | -$154,131,139 | -$91,692,396 | TBPH, NVRO, PTI, GLPG, ANAB | 13F-HR | 15 May 2017, 15:23 |
| Q4 2016 | 77 | $741,783,000 | +$99,836,013 | -$135,955,174 | -$36,119,161 | PTI, TBPH, NVRO, ALDR, EGRX | 13F-HR | 14 Feb 2017, 15:22 |
| Q3 2016 | 84 | $906,836,000 | +$178,755,829 | -$149,619,442 | +$29,136,387 | ALDR, NVRO, TBPH, NERV, PTI | 13F-HR | 14 Nov 2016, 14:58 |
| Q2 2016 | 84 | $705,177,000 | +$137,642,795 | -$122,905,069 | +$14,737,726 | ALDR, NVRO, HRTX, TSRO, NKTR | 13F-HR | 15 Aug 2016, 16:12 |
| Q1 2016 | 84 | $663,828,000 | +$141,591,686 | -$56,034,007 | +$85,557,679 | ALDR, HRTX, SAGE, OMER, NKTR | Restatement | 17 May 2016, 16:50 |
| Q4 2015 | 82 | $835,862,000 | +$138,744,837 | -$44,107,537 | +$94,637,300 | ALKS, DYAX, HRTX, EGRX, NBIX | 13F-HR | 16 Feb 2016, 16:11 |
| Q3 2015 | 87 | $626,096,000 | +$87,625,677 | -$53,387,845 | +$34,237,832 | HRTX, ALKS, NBIX, DYAX, ARDX | 13F-HR | 16 Nov 2015, 16:08 |
| Q2 2015 | 80 | $752,151,000 | +$156,555,009 | -$169,356,194 | -$12,801,185 | ALKS, HRTX, RCPT, ALDR, DYAX | 13F-HR | 14 Aug 2015, 16:22 |
| Q1 2015 | 71 | $647,100,000 | +$102,486,435 | -$193,672,790 | -$91,186,355 | RCPT, ALKS, PBYI, EGRX, BMY | 13F-HR | 15 May 2015, 16:18 |
| Q4 2014 | 70 | $648,511,000 | +$180,451,215 | -$133,765,851 | +$46,685,364 | RCPT, PBYI, CELG, OVAS, ALKS | 13F-HR | 17 Feb 2015, 16:20 |
| Q3 2014 | 65 | $486,175,000 | +$177,975,984 | -$73,535,548 | +$104,440,436 | PBYI, RCPT, JAZZ, DYAX, KERX | 13F-HR | 14 Nov 2014, 11:21 |
| Q2 2014 | 54 | $377,374,000 | +$139,107,808 | -$180,918,214 | -$41,810,406 | RCPT, OMER, QCOR, KPTI, DYAX | 13F-HR | 14 Aug 2014, 11:21 |
| Q1 2014 | 46 | $434,881,000 | +$201,660,856 | -$125,875,806 | +$75,785,050 | MDVN, CBST, PBYI, BMRN, RCPT | 13F-HR | 15 May 2014, 11:20 |
| Q4 2013 | 37 | $344,573,000 | $0 | $0 | $0 | MDVN, CBST, KERX, DYAX, PBYI | 13F-HR | 14 Feb 2014, 10:50 |